Literature DB >> 23909072

Postmenopausal hormone receptor-positive advanced breast cancer.

Roisin M Connolly1, Vered Stearns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23909072

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  3 in total

Review 1.  Running away from side effects: physical exercise as a complementary intervention for breast cancer patients.

Authors:  S Casla; P Hojman; I Márquez-Rodas; S López-Tarruella; Y Jerez; R Barakat; M Martín
Journal:  Clin Transl Oncol       Date:  2014-06-04       Impact factor: 3.405

2.  Identification of Molecular Targets for Predicting Colon Adenocarcinoma.

Authors:  Yansheng Wang; Jun Zhang; Li Li; Xin Xu; Yong Zhang; Zhaowei Teng; Feihu Wu
Journal:  Med Sci Monit       Date:  2016-02-12

Review 3.  E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.

Authors:  Sri Lakshmi Hyndavi Yeruva; Fengmin Zhao; Kathy D Miller; Amye J Tevaarwerk; Lynne I Wagner; Robert J Gray; Joseph A Sparano; Roisin M Connolly
Journal:  NPJ Breast Cancer       Date:  2018-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.